US company petitions FDA to regulate all IVD tests
This article was originally published in RAJ Devices
Executive Summary
US biopharmaceutical company Genentech has filed a citizen petition with the Food and Drug Administration asking the agency to broaden the scope of its regulations to include in vitro diagnostic tests that are developed by clinical laboratory companies for in-house testing to guide therapeutic decision-making1.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.